Sotera Health Company (SHC)

Sotera Health Company (SHC) is a healthcare company (diagnostics & research) based in the United States. The share price is $16.10, down 0.92% on the day, which values the company at $4.6B. Price as of 17 Nov 2026, 17:15 UTC, from Yahoo Finance.

Key facts

Share price
$16.10−0.92% today
Market value
$4.6B
P/E ratio
26.8×last 12 months
Forward P/E
15.1×
Funk Score
57/100
Against its own history
Below its usual priceusual price $20.33
200-week average
$15.117% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Sotera Health Company in more detail

SHC trades at 26.8× its last twelve months' earnings, 15.1× next year's expected earnings, 3.7× sales. Measured against its own history, the price is 21% below what its usual multiples would imply ($20.33) — below its usual price. It sits 7% above its 200-week average of $15.11.

Over the last five fiscal years Sotera Health Company has compounded revenue 7.3% a year, free cash flow 17.3% a year. Its Funk Score is 57 out of 100 (financial strength 2.3, profitability 6.5, growth 6.5, value 7.4, each out of 10).

In its favour: Operating margin is expanding; Five straight years of revenue growth. Worth checking: Altman Z in the distress zone; Share count keeps rising.

6 of the superinvestors tracked here hold SHC, including Adam Katz (6.6% of the portfolio), Anthony Bozza (3.4% of the portfolio), Anand Desai (2.2% of the portfolio).

Superinvestors holding SHC

6 of the investors tracked here report a position in their latest 13F filing.

Sotera Health Company (SHC): questions and answers

What is SHC's P/E ratio?

Sotera Health Company trades at 26.8× its last twelve months' earnings and 15.1× next year's expected earnings. At its fiscal year-ends over the past 4 years the P/E ranged from 57.4× to 93.6×, with a median of 75.4×.

What is SHC's PEG ratio?

Sotera Health Company's PEG ratio is 1.31 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Sotera Health Company's market cap?

Sotera Health Company is valued at $4.6B at a share price of $16.10.

Is SHC overvalued or undervalued?

Against its own history, SHC is below its usual price: the price is 21% below the $20.33 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is SHC above its 200-week moving average?

Yes. SHC is 6.6% above its 200-week average of $15.11. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Sotera Health Company growing?

Over the last five fiscal years Sotera Health Company's revenue grew 7.3% a year.

Cite this page

Funkfolio, “Sotera Health Company (SHC) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/SHC

Underlying data: Yahoo Finance; company filings with the SEC.